FGF23 and congestive heart failure: The basic science leading to the understanding of FGF23 as a cardiorenal connector has led to clinical applications, as demonstrated by Ter Matten et al., who showed that patients with congestive heart failure and elevated levels of FGF23 were volume overloaded, not optimally treated, and had poor outcomes [56].